Aster Angagaw is the former President, ServiceMaster Brands where she served from May 2019 to October 2020 until ServiceMaster Brands was acquired in October 2020. Prior to that from 2016 to 2018, Ms. Angagaw was Chief Executive Officer, Healthcare North America division of Sodexo, a global integrated food service and facilities management company with more than 6,000 employees across the U.S. and Canada. During her 18-year career with Sodexo, Ms. Angagaw had a successful record of accomplishment in operations, strategy and business development, organizational transformation and customer retention, holding many leadership positions with Sodexo, including Senior Vice President, Global Head of Sales and Business Development, Healthcare; Group Vice President, Global Transformation; Senior Vice President, Market Development, Business and Industries US; and Senior Vice President, Strategy, Planning & Quality, Business & Industries US. Ms. Angagaw was appointed to the Board on March 1, 2021.
Mark A. Beck was named Chair of the Board on September 22, 2020 and has been an independent director of Owens & Minor since August 2019. Mr. Beck is the co-founder and CEO of B-Square Precision, LLC, a private company engaged in the acquisition and management of companies that manufacture high-precision tools, dies, molds and components. Mr. Beck currently serves on the Board of Directors and Audit Committee of IDEX Corporation, a global applied solutions business with a focus on health, safety and fluid handling technologies, including its Health & Science Technologies segment. He previously served as President and Chief Executive Officer of JELD-WEN Holding, Inc., one of the world’s largest door and window manufacturers, from November 2015 to February 2018, and was a director of JELD-WEN from May 2016 to February 2018.Prior to JELD-WEN, Mr. Beck served as an Executive Vice President at Danaher Corporation, leading Danaher’s water quality and dental programs, beginning in April 2014. Previously, he spent 18 years with Corning Incorporated in a series of management positions with increasing responsibility, culminating in his appointment as Executive Vice President overseeing Corning’s environmental technologies and life science units in July 2012. He formerly served on the board of directors of Dow-Corning Corporation from 2010 to 2014.
Lieutenant General (three-stars) Bingham retired in September 2019 from the United States Army following a 38-year career in the military. During her military career, Lieutenant General Bingham served as Department of the Army Assistant Chief of Staff for Installation Management from 2016 through her retirement in 2019. Previously, she was Commanding General, US Army Tank-Automotive and Armaments Lifecycle Management Command from 2014 to 2016; Commanding General, White Sands Missile Range from 2012 to 2014; Commandant, US Army Quartermaster School from 2010 to 2012; and Chief of Staff, Combined Arms Support Command and Sustainment Center of Excellence from 2008 to 2010. Lieutenant General Bingham was appointed to the Board on March 5, 2020.
Robert J. Henkel is the President, Healthcare Transformation at THEO Executive Group where he leads the organization’s vision, strategy and planning to positively influence transformation of the healthcare industry toward affordable, quality healthcare for all, with particular emphasis on the most vulnerable communities. Mr. Henkel was President and Chief Executive Officer of Ascension Health, one of the nation’s leading non-profit faith based health systems, from 2012 to 2017. Prior to that, he served as COO of Ascension Health from 2004-2011, and Operating Group President of the Great Lakes and Mid-Atlantic region for Ascension Health beginning in 1998. Prior to joining Ascension Health, Mr. Henkel served in various C-Level roles at numerous leading hospitals including Mount Sinai Medical Center, DePaul Health Center and Montefiore Medical Center. Mr. Henkel was appointed to the Board on October 1, 2019.
Mr. Klemash has been a Partner with Ernst & Young LLP (EY) since 1997, and is currently the Lead Partner with the EY Americas Center for Board Matters (CBM), a position he has held since 2016. Prior to that Mr. Klemash held multiple Managing Partner positions and leadership positions for EY during his 35-year career. Mr. Klemash is a certified public accountant and member of the American Institute of Certified Public Accountants. Mr. Klemash was appointed to the Board on March 1, 2021.
Mark F. McGettrick, retired in December 2018 as Executive Vice President and Chief Financial Ofﬁcer of Dominion Energy Inc., a position he has held since June 2009. In addition, Mr. McGettrick previously served as Executive Vice President, Chief Financial Ofﬁcer and a member of the board of directors of Dominion Energy Midstream GP, LLC, the general partner of Dominion Energy Midstream Partners, LP, from March 2014 until 2018. From January 2003 to 2009, Mr. McGettrick served as Chief Executive Ofﬁcer of the company’s Dominion Generation operating segment. Mr. McGettrick joined Dominion Energy, Inc. in 1980 and during his tenure has held a variety of other management positions in distribution design, accounting, customer service and generation. He currently serves on the board of directors of Virginia Electric and Power Company and Dominion Energy Gas Holdings, LLC, which are wholly-owned subsidiaries of Dominion Energy, Inc. Mr. McGettrick was appointed to the Board on March 1, 2018.
Mr. Pesicka was named President & Chief Executive Officer of Owens & Minor, effective March 7, 2019, and was appointed to the Board of Directors at the same time. Prior to that, Mr. Pesicka served as an independent consultant and advisor in the healthcare, life science and distribution industries since January 2016. From January 2000 through April 2015, he served in various roles of increasing responsibility at Thermo Fisher Scientific, a $17 billion manufacturer and supplier of a range of products to the research, healthcare, industrial and safety markets, including most recently as Chief Commercial Officer & Senior Vice President. Before joining Thermo Fisher Scientific, Mr. Pesicka spent eight years at TRW Inc., in a variety of finance roles and three years with PricewaterhouseCoopers as an auditor.
Michael C. Riordan is the former Co-Chief Executive Officer and Director of Prisma Health. Previously, Mr. Riordan served as chief executive for the Greenville Health System (GHS) from 2006 to 2016, when GHS merged with Palmetto Health to form Prisma Health, the largest health system in South Carolina. Following the merger, Mr. Riordan assumed the role of Co-Chief Executive Officer and Director of Prisma where he served until his retirement in June of 2019. Prior to Prisma, Mr. Riordan was President & Chief Executive Officer of the University of Chicago Hospitals and Health System from 2001 to 2006. He previously served as Chief Operating Officer at Emory University Hospital and before that held numerous administrative roles at Crawford Long Hospital in Atlanta, Georgia. He also spent three years as an infantry officer in the United States Marine Corps. Mr. Riordan was appointed to the Board on December 5, 2019.